Poland· PL-100494126
Pixoroso
A rosuvastatin und perindopril product containing rosuvastatinum + tert-butylamini perindoprilum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rosuvastatin und perindopril is registered in 2 of 19 countries.
Countries holding a registration under ATC C10BX21 (rosuvastatin und perindopril), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Rosuvastatin und perindopril · ATC C10BX21
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Rosuvastatinum + tert-Butylamini perindoprilum
- Manufacturer
- Krka, d.d., Novo mesto
- Country
- Poland (PL)
- ATC code
- C10BX21
- ATC class
- Rosuvastatin und Perindopril
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin03838989783150
- gtin03838989783112
- gtin03838989783198
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C10BX21
Rosuvastatin und perindopril, as other registers publish it.
- PolandPixorosoKrka, d.d., Novo mesto
- PolandPixorosoKrka, d.d., Novo mesto
- PolandPixorosoKrka, d.d., Novo mesto
- CzechiaPIXOROSOKrka, d.d., Novo mesto, Novo mesto
- CzechiaPIXOROSOKrka, d.d., Novo mesto, Novo mesto
- CzechiaPIXOROSOKrka, d.d., Novo mesto, Novo mesto
- CzechiaPIXOROSOKrka, d.d., Novo mesto, Novo mesto
- CzechiaPIXOROSOKrka, d.d., Novo mesto, Novo mesto
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9c64b65-7865-4eb7-b091-6747c42c334e GET /v1/drugs/d9c64b65-7865-4eb7-b091-6747c42c334e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "20 mg + 4 mg",
"packaging": "03838989783150 ¦ Rp ¦ 163088\n60 tabl.\n03838989783112 ¦ Rp ¦ 163089\n30 tabl.\n03838989783198 ¦ Rp ¦ 163090\n90 tabl.",
"substance": "Rosuvastatinum 20 mg + tert-Butylamini perindoprilum 4 mg",
"common_name": "Rosuvastatinum + tert-Butylamini perindoprilum",
"pl_product_id": "100494126",
"pozwolenie_nr": "29184",
"auth_procedure": "DCP",
"authorisation_validity": "2030-07-10"
}See everything about rosuvastatin und perindopril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.